Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 12/31/18
Due: 12/31/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The AMEND TS Early Feasibility Study is a Prospective, Single-arm, Multi-center Study to Evaluate the Safety and Function of the AMEND(TM) Trans-Septal System for MR Reduction: Up to 15 Subjects Will be Enrolled in up to 7 Investigational Centers in the U.S. and Canada With a 30d Safety Endpoint | NCT06951672 | Valcare Medical Ltd. | user2@example.com | None | 2025-06-30 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| AMENDTM Mitral Valve Repair System, Annuloplasty Ring Applied in a Transcatheter Method | NCT02602613 | Valcare Medical Ltd. | user2@example.com | None | 2015-12-31 | 2018-12-31 | 2019-12-31 | - | - | 2025-07-14 |